Butterfly Network, INC 8-K filings

Butterfly Network, Inc. announces the resignation of Dr. Erica Schwartz from its Board of Directors, effective August 5, 2026, following her confirmation as Director of the Centers for Disease Control and Prevention.

Butterfly Network announced record Q2 2026 revenue of $32.6 million, a 39% year-over-year increase, and improved adjusted EBITDA loss, exceeding guidance.

Butterfly Network announced the appointment of Caroll H. Neubauer to its Board of Directors, effective May 18, 2026, strengthening its healthcare industry expertise.

Butterfly Network announces first quarter 2026 financial results, exceeding revenue expectations with 25% year-over-year growth and improved gross margins.

Butterfly Network reported record quarterly revenue of $31.5 million in Q4 2025, marking 41% year-over-year growth and achieving its first quarter of positive operating cash flow.

The New York Stock Exchange has announced the delisting and immediate suspension of trading for Butterfly Network's public warrants due to abnormally low selling prices.

Butterfly Network anticipates at least 17% year-over-year revenue growth for the fourth quarter of 2025, driven by its handheld ultrasound business.

Butterfly Network's subsidiary BFLY Operations, Inc. entered a five-year Co-Development and Licensing Agreement with Midjourney, Inc. for its ultrasound technology.

Butterfly Network reports 5% YoY revenue growth and record low cash burn in Q3 2025, reaffirming full-year revenue guidance despite a significant inventory write-down.

Butterfly Network, Inc. announced the appointment of John Doherty as Executive Vice President, Chief Financial Officer, effective December 8, 2025.

Butterfly Network reported its highest quarterly revenue and gross margins in company history for Q2 2025, alongside a significant reduction in cash usage and the departure of its Chief Financial and Operations Officer.

Butterfly Network, Inc. announced that its stockholders re-elected all seven directors, ratified Deloitte & Touche LLP as its independent auditor, and approved executive compensation in a non-binding advisory vote at its 2025 Annual Meeting.

Butterfly Network announces a 20% year-over-year revenue increase in Q1 2025, driven by strong U.S. sales and higher iQ3 probe prices, while reaffirming its full-year revenue and adjusted EBITDA guidance.

Butterfly Network reports record quarterly revenue of $22.4 million, a 35% year-over-year increase, and a 59% reduction in net loss for Q4 2024.

Butterfly Network, Inc. has announced the pricing of a public offering of 24,000,000 shares of its Class A common stock at $3.15 per share, expecting gross proceeds of approximately $75.6 million.

Butterfly Network announces a proposed public offering of Class A common stock while estimating a cash balance of $92.8 million as of December 31, 2024, pending final audit.

Butterfly Network reports preliminary unaudited revenue growth of approximately 35% year-over-year for the fourth quarter of 2024.

Butterfly Network announced a 33% year-over-year revenue increase in Q3 2024, alongside improved full-year revenue and adjusted EBITDA guidance.

Butterfly Network reported record quarterly revenue of $21.5 million in Q2 2024, a 16% year-over-year increase, and raised its full-year adjusted EBITDA guidance.

Butterfly Network's stockholders approved a new employee stock purchase plan and amendments to the company's charter at the 2024 annual meeting.

Butterfly Network reported a strong first quarter with 14% revenue growth and significant reductions in net loss and cash usage, but also received a notice from the NYSE regarding its stock price falling below the minimum listing requirement.

Butterfly Network announced its fourth quarter and full year 2023 financial results, exceeding revenue expectations, completing significant cost reductions, and launching its next-generation iQ3 ultrasound device.